Health
New partnership aims to advance predictive tests for multiple myeloma in Ireland – News-Medical.Net
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the second most common blood cancer in Ireland.
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma (MM), the second most common blood cancer in Ireland.
The study will be carried out at Beaumont Hospital Dublin and run through the Blood Cancer Network Ireland with several other cancer hospitals in Ireland participating. It represents a collaboration between RCSI University of Medicine and Health Sciences and SkylineDx with fun…
-
General24 hours agoVictorian school teacher charged with soliciting child abuse material
-
General15 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News21 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News19 hours agoPalestine protesters forced into last-minute reroute